Complex Case Spotlight
An intraoperative finding of a lung tumor invading the hilar lymph node and pulmonary artery spurred an innovative procedure.
With ECMO support and a right-sided approach, the surgical team completed the surgery in just over two hours—discharging the patient the next day.
Expert Perspectives
Dr. Doreen Addrizzo-Harris discusses her novel phage therapy research targeting drug-resistant lung mycobacterium.
Surgical Innovation
The landmark surgery followed the nation’s first fully robotic single lung transplant by the NYU Langone team just one month prior.
Advancing Science
Study shows inflammatory gene signature in tumor-adjacent lung tissue is the strongest clinical predictor of cancer progression.
Add-on therapy significantly improves function, risk, and survival in a difficult-to-treat cardiopulmonary condition.
Vote Now
